Arteris, Inc. (NASDAQ:AIP) Short Interest Down 23.3% in November

Arteris, Inc. (NASDAQ:AIP) was the target of a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 391,100 shares, a decrease of 23.3% from the November 15th total of 509,900 shares. Approximately 1.6% of the shares of the company are sold short. Based on an average trading volume of 111,700 shares, the short-interest ratio is presently 3.5 days.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities restated a “buy” rating and issued a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.

Arteris Stock Performance

Shares of Arteris stock traded up $0.19 during mid-day trading on Friday, hitting $10.33. The stock had a trading volume of 270,325 shares, compared to its average volume of 165,448. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The firm has a 50-day moving average of $7.94 and a two-hundred day moving average of $7.81. Arteris has a 12-month low of $4.83 and a 12-month high of $10.37.

Insider Buying and Selling at Arteris

In related news, Director Isabelle F. Geday sold 15,550 shares of Arteris stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total value of $140,416.50. Following the completion of the transaction, the director now owns 121,213 shares in the company, valued at approximately $1,094,553.39. This trade represents a 11.37 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $7.35, for a total value of $36,750.00. Following the transaction, the chief financial officer now owns 219,659 shares of the company’s stock, valued at $1,614,493.65. This trade represents a 2.23 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 72,461 shares of company stock worth $586,642. Company insiders own 33.70% of the company’s stock.

Institutional Investors Weigh In On Arteris

A number of institutional investors have recently modified their holdings of AIP. US Bancorp DE acquired a new stake in shares of Arteris during the 3rd quarter worth about $34,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Arteris during the 2nd quarter worth $86,000. Algert Global LLC purchased a new stake in shares of Arteris during the 2nd quarter worth approximately $115,000. MetLife Investment Management LLC grew its holdings in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after purchasing an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Arteris in the third quarter valued at approximately $226,000. 64.36% of the stock is owned by institutional investors and hedge funds.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.